FibroBiologics (FBLG) Competitors $0.52 0.00 (-0.62%) As of 12:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBLG vs. ALTS, OVID, VXRT, CNTB, QNCX, HYPD, ATRA, IFRX, XBIT, and IRDShould you be buying FibroBiologics stock or one of its competitors? The main competitors of FibroBiologics include ALT5 Sigma (ALTS), Ovid Therapeutics (OVID), Vaxart (VXRT), Connect Biopharma (CNTB), Quince Therapeutics (QNCX), Hyperion DeFi (HYPD), Atara Biotherapeutics (ATRA), InflaRx (IFRX), XBiotech (XBIT), and Opus Genetics (IRD). These companies are all part of the "pharmaceutical products" industry. FibroBiologics vs. Its Competitors ALT5 Sigma Ovid Therapeutics Vaxart Connect Biopharma Quince Therapeutics Hyperion DeFi Atara Biotherapeutics InflaRx XBiotech Opus Genetics ALT5 Sigma (NASDAQ:ALTS) and FibroBiologics (NASDAQ:FBLG) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations. Is ALTS or FBLG more profitable? FibroBiologics has a net margin of 0.00% compared to ALT5 Sigma's net margin of -74.89%. ALT5 Sigma's return on equity of -179.27% beat FibroBiologics' return on equity.Company Net Margins Return on Equity Return on Assets ALT5 Sigma-74.89% -179.27% -16.28% FibroBiologics N/A -710.25%-118.02% Which has more volatility and risk, ALTS or FBLG? ALT5 Sigma has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Comparatively, FibroBiologics has a beta of -0.73, meaning that its share price is 173% less volatile than the S&P 500. Which has higher valuation and earnings, ALTS or FBLG? ALT5 Sigma has higher revenue and earnings than FibroBiologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioALT5 Sigma$12.53M6.87-$6.24MN/AN/AFibroBiologicsN/AN/A-$11.16M-$0.36-1.44 Do analysts recommend ALTS or FBLG? FibroBiologics has a consensus price target of $12.50, suggesting a potential upside of 2,303.85%. Given FibroBiologics' stronger consensus rating and higher possible upside, analysts plainly believe FibroBiologics is more favorable than ALT5 Sigma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ALT5 Sigma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals hold more shares of ALTS or FBLG? 6.3% of ALT5 Sigma shares are held by institutional investors. 4.9% of ALT5 Sigma shares are held by company insiders. Comparatively, 20.8% of FibroBiologics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to ALTS or FBLG? In the previous week, FibroBiologics had 1 more articles in the media than ALT5 Sigma. MarketBeat recorded 1 mentions for FibroBiologics and 0 mentions for ALT5 Sigma. ALT5 Sigma's average media sentiment score of 0.00 equaled FibroBiologics'average media sentiment score. Company Overall Sentiment ALT5 Sigma Neutral FibroBiologics Neutral SummaryALT5 Sigma and FibroBiologics tied by winning 6 of the 12 factors compared between the two stocks. Get FibroBiologics News Delivered to You Automatically Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBLG vs. The Competition Export to ExcelMetricFibroBiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.08M$3.15B$5.76B$10.50BDividend YieldN/A2.36%5.61%4.58%P/E Ratio-1.4621.0376.6326.90Price / SalesN/A451.34551.24127.98Price / CashN/A44.8325.8131.15Price / Book6.509.8413.666.52Net Income-$11.16M-$52.73M$3.29B$271.58M7 Day Performance-1.79%3.65%2.40%3.67%1 Month Performance-11.65%5.95%4.81%8.14%1 Year Performance-81.16%17.38%81.05%26.94% FibroBiologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBLGFibroBiologics2.8471 of 5 stars$0.52-1.6%$12.50+2,303.8%-84.0%$22.08MN/A-1.4610ALTSALT5 Sigma0.0399 of 5 stars$3.92-6.2%N/A+85.7%$90.33M$12.53M0.00170OVIDOvid Therapeutics4.2217 of 5 stars$1.28+1.6%$3.10+142.2%+12.2%$89.60M$570K-2.4260Positive NewsVXRTVaxart2.0058 of 5 stars$0.37-6.0%$2.00+445.6%-54.1%$89.29M$47.40M-1.36120Gap DownCNTBConnect Biopharma3.6773 of 5 stars$1.60+2.6%$7.00+337.5%+28.5%$86.93M$26.03M0.00110Gap UpQNCXQuince Therapeutics2.919 of 5 stars$1.60flat$8.14+408.9%+87.2%$85.94MN/A-1.4760Gap DownHYPDHyperion DeFi0.4371 of 5 stars$11.56-22.8%$2.00-82.7%-74.6%$85.31M$44.44K-0.2040High Trading VolumeATRAAtara Biotherapeutics4.5865 of 5 stars$11.94-1.5%$21.00+75.9%+57.9%$85.12M$128.94M-27.77330Positive NewsIFRXInflaRx3.2553 of 5 stars$1.23-2.4%$6.20+404.1%-12.9%$84.59M$162.83K-1.5460Gap UpXBITXBiotech2.2273 of 5 stars$2.72-1.1%N/A-59.5%$83.84M$4.01M-2.96100News CoveragePositive NewsIRDOpus Genetics2.4388 of 5 stars$1.37-0.7%$7.33+435.3%N/A$82.67M$10.99M-0.7114 Related Companies and Tools Related Companies ALTS Competitors OVID Competitors VXRT Competitors CNTB Competitors QNCX Competitors HYPD Competitors ATRA Competitors IFRX Competitors XBIT Competitors IRD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FBLG) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FBLG Stock Alerts